Invenomic Capital Management
Invenomic Capital Management reported 115 stocks worth $1.7B in its 13F filing for Q2 2026, filed Aug 14, 2026. Its largest holdings are GPN (3.8%), UHS (3.8%) and WDAY (3.5%). Compared with Q1 2026, the fund opened new positions in BDX, CHTR and INTU, added to UHS, XRAY and SPSC, trimmed GPN, WDAY and PVH and sold out of CHRD, TFX and AKAM.
Holdings
| # | Stock | Value | Weight | Shares | Change | Shares, 8 qtrs | Held |
|---|---|---|---|---|---|---|---|
| 1 |  GPN Global Pmts Inc | $64M | 3.8% | 882K | −33K (−4%) | 8 of 8 | |
| 2 |  UHS Universal Hlth Svcs Inc | $63.5M | 3.8% | 427K | +242K (+131%) | 4 of 8 | |
| 3 |  WDAY Workday Inc | $58.3M | 3.5% | 476K | −84K (−15%) | 2 of 8 | |
| 4 |  XRAY Dentsply Sirona Inc | $52.1M | 3.1% | 4.9M | +520K (+12%) | 8 of 8 | |
| 5 |  SPSC Sps Comm Inc | $49.7M | 3.0% | 869K | +605K (+229%) | 2 of 8 | |
| 6 |  PVH Pvh Corporation | $42.7M | 2.5% | 575K | −188K (−25%) | 6 of 8 | |
| 7 |  BDX Becton Dickinson & Co | $41.3M | 2.5% | 273K | New position | 1 of 8 | |
| 8 |  FIS Fidelity Natl Information SV | $41.2M | 2.5% | 1.1M | +26K (+3%) | 6 of 8 | |
| 9 |  CHTR Charter Communications Inc N | $40.2M | 2.4% | 282K | New position | 1 of 8 | |
| 10 |  EGO Eldorado Gold Corp New | $36M | 2.1% | 1.2M | −276K (−19%) | 8 of 8 |
Positions at Jun 30, 2026, as reported. Change is against the fund's Q1 2026 filing; weight is the share of the fund's reported stocks.
Sold out
held in Q1 2026, gone in Q2 2026| Stock | Value last quarter | Shares sold |
|---|---|---|
 CHRD Chord Energy Corporation | $73.2M | 515K |
 TFX Teleflex Incorporated | $52.2M | 436K |
 AKAM Akamai Technologies Inc | $46.6M | 406K |
 RNG Ringcentral Inc | $30.2M | 812K |
 ACHC Acadia Healthcare Company in | $27.7M | 1.2M |
🔒 Free account: see all 30.
Options
valued at the underlying shares| Stock | Type | Value | Shares | Change |
|---|---|---|---|---|
 TLT Ishares TR | Call | $302K | 3,500 | 0 |
Reported value
last 8 quartersThe value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.
Filings for Q2 2026
straight from the SEC| Filed | Form | Quarter | |
|---|---|---|---|
| Aug 14, 2026 | 13F-HR | Q2 2026 | SEC filing ↗ |
Other superinvestors
All hedge fund holdings →Invenomic Capital Management 13F FAQ
What does Invenomic Capital Management own?
Invenomic Capital Management reported 115 stocks worth $1.7B in its 13F filing for Q2 2026, filed Aug 14, 2026. Its largest holdings are GPN (3.8%), UHS (3.8%) and WDAY (3.5%). The table above lists every position in the filing (the top 10 without an account).
What did Invenomic Capital Management buy and sell in Q2 2026?
Compared with Q1 2026: 21 new positions, 23 added to, 68 trimmed and 54 sold out. New positions include BDX, CHTR and INTU. It sold all of CHRD, TFX and AKAM.
When will Invenomic Capital Management file its next 13F?
Holdings as of Sep 30, 2026 are due by Nov 16, 2026. The filing appears on this page within minutes of reaching the SEC.
How much is Invenomic Capital Management's portfolio worth?
The Q2 2026 filing reports $1.7B in US stocks. That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.